Search Results - "Nault, Audrey"
-
1
Adenylate cyclase type 9 antagonizes cAMP accumulation and regulates endothelial signalling involved in atheroprotection
Published in Cardiovascular research (31-03-2023)“…The adenylate cyclase type 9 (ADCY9) gene appears to determine atherosclerotic outcomes in patients treated with dalcetrapib. In mice, we recently demonstrated…”
Get full text
Journal Article -
2
ADCY9 (Adenylate Cyclase Type 9) Inactivation Protects From Atherosclerosis Only in the Absence of CETP (Cholesteryl Ester Transfer Protein)
Published in Circulation (New York, N.Y.) (16-10-2018)“…BACKGROUND:Pharmacogenomic studies have shown that ADCY9 genotype determines the effects of the CETP (cholesteryl ester transfer protein) inhibitor dalcetrapib…”
Get full text
Journal Article -
3
Abstract 624: Interactions Between Adenylate Cyclase Type 9 (ADCY9) and Cholesteryl Ester Transfer Protein (CETP) in Atherosclerosis
Published in Arteriosclerosis, thrombosis, and vascular biology (01-05-2018)“…Abstract only Pharmacogenomic studies have shown that ADCY9 genotype determines the effects of the cholesteryl ester transfer protein (CETP) inhibitor…”
Get full text
Journal Article -
4
Adenylate Cyclase Type 9 (ADCY9) Inactivation Protects from Atherosclerosis Only in the Absence of Cholesteryl Ester Transfer Protein (CETP)
Published in Circulation (New York, N.Y.) (19-04-2018)“…-Pharmacogenomic studies have shown that genotype determines the effects of the cholesteryl ester transfer protein (CETP) inhibitor dalcetrapib on…”
Get full text
Journal Article